...
首页> 外文期刊>Protein Expression and Purification >B-cell epitope of beta toxin of Clostridium perfringens genetically conjugated to a carrier protein: Expression, purification and characterization of the chimeric protein
【24h】

B-cell epitope of beta toxin of Clostridium perfringens genetically conjugated to a carrier protein: Expression, purification and characterization of the chimeric protein

机译:基因与载体蛋白缀合的产气荚膜梭菌β毒素的B细胞表位:嵌合蛋白的表达,纯化和表征

获取原文
获取原文并翻译 | 示例
           

摘要

Beta toxin (btx) is the prime virulence factor for the pathogenesis of Clostridium perfringens type C strain, known to cause necrotic enteritis and enterotoxaemia in mammalian species. The existing vaccines targeting btx are formaldehyde inactivated culture filtrates of Clostridium. These filtrates raise antigenic load in the host leading to nonspecific and poor responses. The present study aimed to overcome these drawbacks and generate a chimeric protein carrying in silica identified B-cell epitope of btx fused with a carrier protein as a vaccine candidate. Using bioinformatic tools, three stretches of amino acids were predicted as putative B-cell epitopes. One of the epitopes spanning 140-156 amino acid residues was genetically conjugated with B-subunit of heat labile enterotoxin (LTB) of Escherichia coli and expressed as a translational fusion in Vibrio cholerae secretory expression system. High level expression of the recombinant fusion protein rLTB-Btx(140-156) was obtained and the protein was successfully purified. The recombinant protein retained the native LTB property to pentamerize and bind to GM(1) ganglioside receptor of LTB. The antigenicity of both the epitope and the carrier protein was maintained in fusion protein as indicated by immunoblotting against anti-LTB and anti-btx antibody. The rLTB-Btx(140-156) fusion protein therefore can be evaluated as a potential vaccine candidate against C. perfringens. (C) 2014 Elsevier Inc. All rights reserved.
机译:β毒素(btx)是产气荚膜梭状芽孢杆菌C型菌株发病机理的主要毒力因子,已知在哺乳动物物种中引起坏死性肠炎和肠毒素血症。靶向btx的现有疫苗是梭状芽孢杆菌的甲醛灭活培养滤液。这些滤液增加宿主中的抗原负荷,导致非特异性和不良应答。本研究旨在克服这些缺点并产生在二氧化硅中携带的嵌合蛋白,该嵌合蛋白鉴定了与载体蛋白融合的btx的B细胞表位作为候选疫苗。使用生物信息学工具,预测了三个氨基酸段作为推定的B细胞表位。跨越140-156个氨基酸残基的表位之一与大肠杆菌的热不稳定肠毒素(LTB)的B亚基遗传偶联,并在霍乱弧菌分泌表达系统中表达为翻译融合体。获得高水平表达的重组融合蛋白rLTB-Btx(140-156),并成功纯化了该蛋白。重组蛋白保留了LTB的天然LTB特性,使其与LTB的GM(1)神经节苷脂受体结合。如针对抗LTB和抗btx抗体的免疫印迹所表明的,表位和载体蛋白两者的抗原性在融合蛋白中得以维持。因此,rLTB-Btx(140-156)融合蛋白可作为抗产气荚膜梭菌的潜在候选疫苗进行评估。 (C)2014 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号